Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights – Nasdaq

Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights  Nasdaq

LEXINGTON, Mass., March 21, 2019– Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially.

from https://www.nasdaq.com/press-release/translate-bio-announces-fourth-quarter-and-full-year-2018-financial-results-and-reviews-recent-20190321-00939
via Accredited Translation services